Orphan drug exclusivity gives pharmaceutical companies seven years of market protection for rare-disease treatments, encouraging development where profits are low. Learn how it works, why prices are high, and what’s changing in 2026.
25 Mar
Hidradenitis Suppurativa: Painful Nodules and Biologic Therapy
6 May
Carbamazepine as a CYP Inducer: Managing Drug Interactions Across Multiple Classes
12 Jan
Schizophrenia: How Antipsychotic Medications Work and Which Atypical Agents Are Most Effective
11 Oct
Zyban (Bupropion) vs Other Smoking‑Cessation Options: A Practical Comparison
12 Jul
Theophylline Levels: Why Narrow Therapeutic Index Monitoring is Critical